Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040060
Filing Date
2023-11-09
Accepted
2023-11-09 16:15:54
Documents
62
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 918813
2 ex31-1.htm EX-31.1 11767
3 ex31-2.htm EX-31.2 12346
4 ex32-1.htm EX-32.1 7518
5 ex32-2.htm EX-32.2 7494
  Complete submission text file 0001493152-23-040060.txt   4023925

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ogen-20230930.xsd EX-101.SCH 36113
7 XBRL CALCULATION FILE ogen-20230930_cal.xml EX-101.CAL 44844
8 XBRL DEFINITION FILE ogen-20230930_def.xml EX-101.DEF 126894
9 XBRL LABEL FILE ogen-20230930_lab.xml EX-101.LAB 278328
10 XBRL PRESENTATION FILE ogen-20230930_pre.xml EX-101.PRE 213458
56 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 428950
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 231392669
SIC: 2834 Pharmaceutical Preparations